October 28, 2025
Eli Lilly to Invest $1 Billion in Hyderabad Contract Manufacturing and Oversight Facility
Eli Lilly will invest over $1 billion in a new manufacturing and oversight facility in Hyderabad to boost global medicine supply and create jobs in Telangana.
Read More
October 27, 2025
Novartis Nears $70-Per-Share Deal to Acquire Avidity Biosciences
Novartis AG is reportedly nearing a deal to acquire Avidity Biosciences for over $70 per share, expanding its focus on biotechnology and RNA-based therapeutics.
Read More
October 24, 2025
Strides Pharma to Market WHO-Prequalified Generic Contraceptive DMPA-SC in Africa
Strides Pharma’s subsidiary will market the world’s first WHO-prequalified generic DMPA-SC, Medogen SubQ, across Africa to improve women’s access to affordable reproductive health solutions.
Read More
October 23, 2025
Alkermes Enters Sleep Medicine Market with $2.1 Billion Avadel Acquisition
Alkermes is acquiring Avadel Pharmaceuticals for up to $2.1 billion, gaining access to Lumryz and entering the fast-growing sleep medicine market.
Read More
October 20, 2025
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Prothya Biosolutions Acquisition
Accord Plasma B.V., a subsidiary of Intas Pharmaceuticals, has acquired Prothya Biosolutions Belgium BV, strengthening its global presence in plasma-derived therapies.
Read More
October 17, 2025
Roquette Opens New Pharmaceutical Innovation Center in Brazil to Boost Latin American Collaboration
Roquette has launched its Health & Pharma Solutions Innovation Center in São Paulo, boosting its focus on advanced drug delivery and innovative health solutions.
Read More
October 16, 2025
Adtalem and Google Cloud Launch AI Credential Program for Healthcare Professionals
Adtalem Global Education and Google Cloud will launch an AI credential program in 2026 to train students and healthcare professionals in using tools like Gemini and Vertex AI for clinical decision-making.
Read More
October 15, 2025
Pfizer CEO Urges Greater U.S.–China Collaboration in Pharma Innovation
Pfizer CEO Albert Bourla urged stronger U.S.-China pharmaceutical collaboration, noting China now contributes nearly 30% of global drug development.
Read More
October 14, 2025
Coveris Partners with SABIC for Closed-Loop Medical Packaging Initiative
Coveris and SABIC have launched the world’s first closed-loop recycling system for medical packaging, turning non-contaminated hospital waste into new sterile pouches.
Read More
October 13, 2025
Natco Pharma to Acquire Majority Stake in South Africa’s Adcock Ingram for Approx. USD 240 Million
India’s Natco Pharma is acquiring a significant stake in South Africa’s Adcock Ingram for around USD 240 million, making the 135-year-old company privately owned by Natco and majority shareholder Bidvest.
Read More
October 10, 2025
Samsung Biologics Launches ExellenS™ Framework
Samsung Biologics has launched ExellenS™, a new framework to enhance and streamline biomanufacturing across its network, leveraging its expertise in plant design, digitalization, and operational excellence.
Read More
October 9, 2025
Alterity Therapeutics Presents Positive Phase 2 Data for ATH434 in Multiple System Atrophy
Alterity Therapeutics reported positive Phase 2 results for ATH434 in Multiple System Atrophy, showcasing its potential as a first-in-class, disease-modifying therapy.
Read More
October 8, 2025
Merck Completes $10 Billion Acquisition of Verona Pharma
Merck (MSD outside the U.S. and Canada) has completed its $10 billion acquisition of Verona Pharma, making it a wholly owned subsidiary and delisting its shares from Nasdaq.
Read More
October 7, 2025
Eli Lilly to Invest Over $1 Billion in India to Boost Manufacturing Capacity
Eli Lilly plans to invest over $1 billion in India to expand local manufacturing and supply, leveraging the country’s skilled pharmaceutical workforce.
Read More
October 6, 2025
Hikma and Celltrion Expand Partnership to Boost Biosimilar Access in MENA
Hikma Pharmaceuticals and South Korea’s Celltrion have partnered to launch six biosimilars in the MENA region, improving access to affordable treatments for cancer, immune, eye, and bone-related diseases.
Read More
October 3, 2025
India to Host Second WHO Global Summit on Traditional Medicine
WHO and the Government of India will co-host the Second Global Summit on Traditional Medicine in New Delhi from 17–19 December 2025, focusing on global collaboration and innovation in traditional medicine.
Read More
October 1, 2025
Klotho Neurosciences Signs LOI to Acquire Turn Biotechnologies Assets
Klotho Neurosciences (Nasdaq: KLTO) signed an LOI to acquire Turn Biotechnologies’ ERA platform and eTurna RNA system. The deal would expand its longevity therapeutics portfolio.
Read More
September 30, 2025
China’s Pharma Industry Targets First-in-Class Drug Innovation
Chinese pharma is moving from imitation to creating “first-in-class” drugs, aiming for original treatments with greater global impact and advancing its healthcare ambitions.
Read More
September 29, 2025
China Eliminates Import Tax on Indian Pharma
China has cut its 30% import duty on Indian medicines to zero, boosting India’s pharmaceutical exports and expanding global access to affordable drugs.
Read More
September 26, 2025
Trump Announces Pharma Tariffs to Boost U.S. Manufacturing
President Trump announced a 100% tariff on branded and patented drug imports starting October 1, 2025, to boost U.S. manufacturing, while generics are exempt. Companies must begin U.S. facility construction to avoid the tariff.
Read More
September 25, 2025
Trump’s H-1B Visa Fee Hike Sparks Fears of Worsening US Doctor Shortage
The Trump administration’s plan to raise H-1B visa fees up to $100,000 is alarming U.S. healthcare groups, who fear it will worsen the nation’s physician shortage.
Read More
September 24, 2025
Torrent Pharma Gets Approval to Acquire Controlling Stake in JB Chemicals
Torrent Pharmaceuticals has received regulatory approval from South Africa’s Competition Commission to proceed with its acquisition of JB Chemicals & Pharmaceuticals, advancing its strategic expansion.
Read More
September 23, 2025
Corning and SGD Pharma Inaugurate $60 Million Glass Tubing Facility in Hyderabad
US-based Corning and France’s SGD Pharma inaugurated their $60 million joint venture glass tubing plant for pharma products near Hyderabad.
Read More
September 19, 2025
India Expands Pharma Global Capability Centres, Driving Innovation and Jobs
India is becoming a key pharma hub, with 55+ global centres driving innovation and R&D, amid a $236B patent cliff affecting 70 blockbuster drugs by 2030.
Read More
September 18, 2025
Roche to Acquire 89bio in $3.5 Billion Deal, Expanding MASH Pipeline
Roche will acquire 89bio for $14.50 per share in cash, valuing it at $2.4B, with potential CVRs adding up to $3.5B; the deal is expected to close in Q4 2025.
Read More
September 17, 2025
GSK Unveils $30 Billion U.S. Investment Amid Pharma Tariff Threat
GSK (GSK.L) will invest $30B in U.S. R&D and supply chain over five years, aligning with Trump’s push for domestic drug manufacturing amid tariff threats.
Read More
September 16, 2025
aTyr Pharma Shares Plunge After Lung Disease Drug Fails in Late-Stage Trial
aTyr Pharma shares plunged over 80% after its experimental drug efzofitimod failed a late-stage trial for pulmonary sarcoidosis, a chronic lung disease.
Read More
September 15, 2025
Akeso Launches Global Phase II Trial of Cadonilimab in Advanced Liver Cancer
Akeso, Inc. began dosing the first patient in its global Phase II trial testing cadonilimab, a PD-1/CTLA-4 bispecific antibody, combined with lenvatinib versus lenvatinib alone in advanced hepatocellular carcinoma.
Read More
September 12, 2025
Britain Defends Investment Record as Merck Cancels London Research Centre
The UK government defended its investment record after Merck scrapped its £1 billion London research centre, despite construction already underway and a 2027 opening planned.
Read More
September 11, 2025
British Pharma Industry Warns Drug Pricing Policy is Driving Away Foreign Investment
The ABPI warns that Britain’s strict drug pricing policies are deterring foreign investment, with the UK dropping from 2nd place in 2017 to 7th in 2023 for pharma FDI.
Read More
September 10, 2025
Quotient Sciences and CPI Launch Joint Venture to Accelerate RNA Drug Development
Quotient Sciences and CPI have partnered to speed up mRNA drug development by combining Quotient’s Translational Pharmaceutics platform with CPI’s RNA synthesis and LNP expertise.
Read More
September 9, 2025
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular Pipeline
Novartis will acquire Tourmaline Bio for $1.4B to advance pacibekitug, a clinical-stage anti-IL-6 antibody targeting inflammation in atherosclerotic cardiovascular disease.
Read More
September 8, 2025
PacBio Adds EpiCypher to Compatible Program, Expands Chromatin Research Tools
PacBio has partnered with EpiCypher, enabling the use of CUTANA Hia5 enzyme in Fiber-seq assays on HiFi systems, advancing single-molecule chromatin and epigenetic research.
Read More
September 5, 2025
US Plans to Provide Gilead HIV Drug at Cost in High-Burden Countries
The U.S. will provide Gilead’s long-acting HIV drug lenacapavir “at cost” through PEPFAR and the Global Fund, aiming to reach 2 million people in high-burden countries within three years.
Read More
September 4, 2025
India Removes GST on Life and Health Insurance Premiums from September 22
The GST Council has exempted life and health insurance premiums from the 18% tax starting September 22, bringing major relief to policyholders who will now pay only the base premium.
Read More
September 3, 2025
Polpharma Biologics Partners with MS Pharma to Boost Biosimilar Access in MENA
Polpharma Biologics signs licensing deals with MS Pharma to bring three biosimilars to the MENA region. MS Pharma will oversee commercialization, and Polpharma will handle production and supply.
Read More
July 5, 2025
Supporting EU Pharma Success: A GTM Milestone
Through data-led insights, we helped a pharmaceutical client execute a successful drug launch in Europe.
Read More
June 10, 2025
MedTech Expansion in APAC: Insights That Matter
In-depth competitive analysis enabled our client to identify underserved hospital segments and expand strategically.
Read More
May 28, 2025
AI HealthTech Startups Gain Ground with Consumer Insight
AI-driven HealthTech startups are transforming the healthcare space by using consumer insight to develop personalized, predictive, and scalable digital health solutions.
Read More
May 8, 2025
Global Public Health Research Impacting Policy Frameworks
Groundbreaking global public health research is shaping national and international policy frameworks, leading to more informed, data-driven decisions for population health.
Read More